Other languages Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Real-time Estimate Cboe BZX Other stock markets 18:43:49 29/04/2024 BST			5-day change	1st Jan Change
278.9 ^USD	+1.06%		-0.63%	-13.79%

03:41pm	RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	MT
04-26	Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	04-26
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	04-11
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	04-10
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	03-25
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	03-20
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	03-20
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	02-29
Bio Rad Labs rises after posting upbeat fourth-quarter profit	02-15
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	02-15
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-15
Bio-Rad Laboratories, Inc. Appoints Norman Schwartz as Principal Financial Officer	02-14
Bio-rad Laboratories Insider Sold Shares Worth $358,992, According to a Recent SEC Filing	12-13
Bio-Rad Laboratories, Inc. Announces Resignation of Dara Grantham Wright as Executive Vice-President and President, Effective January 12, 2024	12-07
Bio-rad Laboratories Insider Sold Shares Worth $195,874, According to a Recent SEC Filing	11-28
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending	26/10/23
Bio-Rad Laboratories Q3 Non-GAAP Earnings, Sales Decline -- Shares Drop After Hours	26/10/23
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Viavi Solutions Appoints New CFO	18/10/23
Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Executive Vice-President and Principal Financial Officer, Effective November 6, 2023	17/10/23
Bio-Rad Laboratories EVP Ernst Sells 2,350 Shares for $929,667	31/08/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Other languages

Filters